These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10967185)

  • 1. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.
    Korshunov A; Golanov A; Timirgaz V
    J Neurol Sci; 2000 Aug; 177(1):72-82. PubMed ID: 10967185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical markers for prognosis of ependymal neoplasms.
    Korshunov A; Golanov A; Timirgaz V
    J Neurooncol; 2002 Jul; 58(3):255-70. PubMed ID: 12187959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic marker analysis in pediatric intracranial ependymomas.
    McLendon RE; Lipp E; Satterfield D; Ehinger M; Austin A; Fleming D; Perkinson K; Lefaivre M; Zagzag D; Wiener B; Gururangan S; Fuchs H; Friedman HS; Herndon JE; Healy P
    J Neurooncol; 2015 Apr; 122(2):255-61. PubMed ID: 25563815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
    Korshunov A; Golanov A; Sycheva R
    J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
    Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
    Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma.
    Araki A; Chocholous M; Gojo J; Dorfer C; Czech T; Heinzl H; Dieckmann K; Ambros IM; Ambros PF; Slavc I; Haberler C
    Acta Neuropathol Commun; 2016 Aug; 4(1):88. PubMed ID: 27550150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in intracranial ependymomas in children.
    Figarella-Branger D; Civatte M; Bouvier-Labit C; Gouvernet J; Gambarelli D; Gentet JC; Lena G; Choux M; Pellissier JF
    J Neurosurg; 2000 Oct; 93(4):605-13. PubMed ID: 11014538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
    Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
    Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
    Suri VS; Tatke M; Singh D; Sharma A
    Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p14ARF protein (FL-132) immunoreactivity in intracranial ependymomas and its prognostic significance: an analysis of 103 cases.
    Korshunov A; Golanov A; Timirgaz V
    Acta Neuropathol; 2001 Sep; 102(3):271-7. PubMed ID: 11585252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.
    Wang M; Zhang R; Liu X; Li D; Qiu C; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
    Clin Neurol Neurosurg; 2018 Feb; 165():1-6. PubMed ID: 29253745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases.
    de Andrade FG; Marie SK; Uno M; Matushita H; Taricco MA; Teixeira MJ; Rosemberg S; Oba-Shinjo SM
    Neuropathology; 2015 Aug; 35(4):312-23. PubMed ID: 25946121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and neovascularization in astrocytic tumors.
    Takekawa Y; Sawada T
    Pathol Int; 1998 Feb; 48(2):109-14. PubMed ID: 9589474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of cell cycle/apoptosis regulators and epidermal growth factor receptor in pediatric intracranial ependymomas.
    Alexiou GA; Stefanaki K; Moschovi M; Patereli A; Prodromou N; Karentzou O
    J Child Neurol; 2011 Feb; 26(2):195-8. PubMed ID: 20713981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients.
    Chen C; Chen L; Yao Y; Qin Z; Chen H
    J Neurooncol; 2016 Mar; 127(1):43-52. PubMed ID: 26615563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
    Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical prognostic markers in intracranial ependymomas: systematic review and meta-analysis.
    Kuncova K; Janda A; Kasal P; Zamecnik J
    Pathol Oncol Res; 2009 Dec; 15(4):605-14. PubMed ID: 19301151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal ependymoma in adults: a multicenter investigation of surgical outcome and progression-free survival.
    Wostrack M; Ringel F; Eicker SO; Jägersberg M; Schaller K; Kerschbaumer J; Thomé C; Shiban E; Stoffel M; Friedrich B; Kehl V; Vajkoczy P; Meyer B; Onken J
    J Neurosurg Spine; 2018 Jun; 28(6):654-662. PubMed ID: 29521579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
    Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of stem cell marker nestin and its correlation with vascular endothelial growth factor and microvascular density in ependymomas.
    Nambirajan A; Sharma MC; Gupta RK; Suri V; Singh M; Sarkar C
    Neuropathol Appl Neurobiol; 2014 Oct; 40(6):714-25. PubMed ID: 24224478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.